These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7917530)
1. Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences. Romain S; Formento JL; Guirou O; Francoual M; Milano G; Martin PM Eur J Cancer; 1994; 30A(6):740-6. PubMed ID: 7917530 [TBL] [Abstract][Full Text] [Related]
2. Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay. Dittadi R; Meo S; Amoroso B; Gion M Cancer Res; 1997 Mar; 57(6):1066-72. PubMed ID: 9067273 [TBL] [Abstract][Full Text] [Related]
3. Determination of oestrogen receptors: application of the Passing-Bablock linear regression technique for comparison of enzyme immunoassay and radioligand binding assay in 1841 breast cancer tumours. Romain S; Dussert C; Martin PM Eur J Cancer; 1991; 27(6):715-20. PubMed ID: 1829910 [TBL] [Abstract][Full Text] [Related]
4. Determination of estrogen and progesterone receptors in human breast cancer cytosols: a comparison between radioligand binding assay (DCC) and enzyme immunoassay (EIA). Cerra M; Cecco L; Montella M; Celentano E; Bonelli P; Tuccillo F Int J Biol Markers; 1996; 11(1):50-2. PubMed ID: 8740643 [No Abstract] [Full Text] [Related]
5. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts. Luqmani YA; Temmim L; Memon A; Ali MA; Parkar AH Int J Cancer; 1997 May; 71(4):526-38. PubMed ID: 9178804 [TBL] [Abstract][Full Text] [Related]
6. Evolution of immunoreactivity of monoclonal antibodies H222 and/or D547 used in the detection of breast cancer estrogen receptors. Varying reactivity of receptor isoforms. Cren H; Lechevrel C; Roussel G; Goussard J J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):519-27. PubMed ID: 1911441 [TBL] [Abstract][Full Text] [Related]
7. Determination of oestrogen receptors by enzyme immunoassay. Weigand RA; Lynch D; Cotter D Eur J Cancer; 1994; 30A(6):888. PubMed ID: 7917554 [No Abstract] [Full Text] [Related]
9. Comparison of ligand binding assay and enzyme immunoassay of oestrogen receptor in human breast cancer cytosols. Experience of the E.O.R.T.C. Receptor Group. Blankenstein MA Breast Cancer Res Treat; 1990 Dec; 17(2):91-8. PubMed ID: 2096997 [TBL] [Abstract][Full Text] [Related]
11. Comparison of enzyme immunoassay with dextran-coated charcoal method in the determination of progesterone receptor in breast cancer cytosols. Noguchi S; Miyauchi K; Imaoka S; Koyama H; Iwanaga T Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1715-9. PubMed ID: 3061826 [TBL] [Abstract][Full Text] [Related]
12. [Determination of estradiol receptors by immunoenzyme technique and by radioligand binding in 2134 breast tumors]. Romain S; Dussert C; Martin PM Bull Cancer; 1991; 78(4):331-40. PubMed ID: 1713518 [TBL] [Abstract][Full Text] [Related]
13. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay. Saccani Jotti G; Johnston SR; Salter J; Detre S; Dowsett M J Clin Pathol; 1994 Oct; 47(10):900-5. PubMed ID: 7962603 [TBL] [Abstract][Full Text] [Related]
14. EORTC external quality assurance program for ER and PgR measurements: trial 1998/1999. European Organisation for Research and Treatment of Cancer. Sweep CG; Geurts-Moespot J Int J Biol Markers; 2000; 15(1):62-9. PubMed ID: 10763143 [TBL] [Abstract][Full Text] [Related]
15. Determination of estrogen receptor in breast cancer using monoclonal antibody technology: results of a multicenter study in the United States. Jordan VC; Jacobson HI; Keenan EJ Cancer Res; 1986 Aug; 46(8 Suppl):4237s-4240s. PubMed ID: 3524804 [TBL] [Abstract][Full Text] [Related]
16. Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols. Goussard J; Lechevrel C; Martin PM; Roussel G Cancer Res; 1986 Aug; 46(8 Suppl):4282s-4287s. PubMed ID: 2425945 [TBL] [Abstract][Full Text] [Related]
17. Significance of the 8S complex in oestrogen receptor recognition. Marsigliante S; Puddefoot JR; Barker S; Goode AW; Vinson GP J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):703-11. PubMed ID: 1958507 [TBL] [Abstract][Full Text] [Related]
18. Evidence for bimodal distribution of breast carcinoma ER and PgR values quantitated by enzyme immunoassay. Mobbs BG; Chapman JA; Sutherland DJ; Ryan E; Tustanoff ER; Ooi TC; Murthy PV Eur J Cancer; 1993; 29A(9):1293-7. PubMed ID: 8343271 [TBL] [Abstract][Full Text] [Related]
19. Quality control requirements in estrogen receptor determination. Bojar H Cancer Res; 1986 Aug; 46(8 Suppl):4249s-4250s. PubMed ID: 3524806 [TBL] [Abstract][Full Text] [Related]
20. Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre study. Gion M; Dittadi R; Leon AE; Bruscagnin G; Pelizzola D; Giovannini G; Giganti M; Messeri G; Quercioli M; Flamini E Eur J Cancer; 1991; 27(8):996-1002. PubMed ID: 1832912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]